Business Description
Entheon Biomedical Corp
NAICS : 325412
SIC : 3741
ISIN : CA5534281038
Share Class Description:
XCNQ:ENBI: Ordinary SharesCompare
Compare
Traded in other countries / regions
ENBI.CanadaENTBF.USA1XU.Germany IPO Date
2018-05-03Description
Entheon Biomedical Corp is a biotechnology research and development company committed to treat addiction and substance use disorders.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.92 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 39.8 | |||||
| 3-Year EPS without NRI Growth Rate | 40.3 | |||||
| 3-Year FCF Growth Rate | 41.8 | |||||
| 3-Year Book Growth Rate | -73.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.97 | |||||
| 9-Day RSI | 48.4 | |||||
| 14-Day RSI | 55.24 | |||||
| 6-1 Month Momentum % | -16.13 | |||||
| 12-1 Month Momentum % | 30 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.2 | |||||
| Quick Ratio | 12.2 | |||||
| Cash Ratio | 11.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -113.9 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -124.4 | |||||
| ROE % | -105.17 | |||||
| ROA % | -90.46 | |||||
| ROIC % | -5383.33 | |||||
| ROCE % | -110.01 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.81 | |||||
| PB Ratio | 6.15 | |||||
| Price-to-Tangible-Book | 5.33 | |||||
| EV-to-EBIT | -3.68 | |||||
| EV-to-EBITDA | -3.68 | |||||
| EV-to-Revenue | 4.76 | |||||
| EV-to-FCF | -3.82 | |||||
| Price-to-Net-Current-Asset-Value | 5.33 | |||||
| Price-to-Net-Cash | 8 | |||||
| Earnings Yield (Greenblatt) % | -27.17 | |||||
| FCF Yield % | -21.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Entheon Biomedical Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 0.25 | ||
| EPS (TTM) (C$) | -0.037 | ||
| Beta | 0.93 | ||
| Volatility % | 234.73 | ||
| 14-Day RSI | 55.24 | ||
| 14-Day ATR (C$) | 0.005777 | ||
| 20-Day SMA (C$) | 0.15925 | ||
| 12-1 Month Momentum % | 30 | ||
| 52-Week Range (C$) | 0.05 - 0.25 | ||
| Shares Outstanding (Mil) | 8.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Entheon Biomedical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Entheon Biomedical Corp Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Entheon Biomedical Corp Frequently Asked Questions
What is Entheon Biomedical Corp(XCNQ:ENBI)'s stock price today?
The current price of XCNQ:ENBI is C$0.16. The 52 week high of XCNQ:ENBI is C$0.25 and 52 week low is C$0.05.
When is next earnings date of Entheon Biomedical Corp(XCNQ:ENBI)?
The next earnings date of Entheon Biomedical Corp(XCNQ:ENBI) is .
Does Entheon Biomedical Corp(XCNQ:ENBI) pay dividends? If so, how much?
Entheon Biomedical Corp(XCNQ:ENBI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers